Understanding Uveitis: Protecting Your Vision
What Is Uveitis?
Uveitis refers to inflammation of the uvea, the middle layer of the eye wall that sits between the outer white layer (the sclera) and the inner layer (the retina). Because the uvea contains a dense network of blood vessels that supply oxygen and nutrients to the eye, inflammation here can quickly affect surrounding structures and vision.
The uvea is made up of three connected parts. The iris is the colored ring you see at the front of the eye. The ciliary body is a ring of tissue just behind the iris that helps the lens adjust focus. The choroid is a thin layer of blood vessels that runs beneath the retina and nourishes it. When any of these structures becomes inflamed, it can disrupt normal eye function and put vision at risk.
Uveitis is classified into four types based on which part of the eye is involved, and knowing the type guides how it is treated.
- Anterior uveitis affects the front of the eye, mainly the iris. This is the most common form.
- Intermediate uveitis involves the ciliary body and the vitreous, the gel-like fluid that fills the middle of the eye.
- Posterior uveitis affects the choroid and the retina at the back of the eye. This type is managed closely by retina specialists and carries the greatest risk for vision loss.
- Panuveitis involves inflammation throughout all layers of the uvea at once.
Uveitis occurs when the blood-ocular barrier, a protective wall that normally keeps immune cells out of the eye, breaks down. Once this barrier is disrupted, white blood cells enter the eye and cause swelling and tissue damage. In autoimmune forms of uveitis, a specific type of immune cell called a T cell becomes activated and targets proteins inside the eye. Research suggests that bacteria in the gut may play a role in triggering this activation, though the exact mechanism is still being studied.
Uveitis can appear suddenly or build gradually over time. An acute episode comes on quickly and may resolve within a few weeks with treatment. Recurrent uveitis means the inflammation returns after quiet periods. Chronic uveitis persists for months or longer and often requires ongoing management to keep inflammation under control and protect vision.
Who Gets Uveitis?
Uveitis affects a broader portion of the population than many people realize, and it can occur at any age. Several underlying health conditions, genetic factors, and environmental exposures influence who is most likely to develop it.
Uveitis is more prevalent than many eye conditions that receive greater public attention. The condition can develop at any age but is most common in adults between 20 and 60. Children are also affected, including those with juvenile idiopathic arthritis, and may develop uveitis without the typical warning signs of pain or redness that adults experience.
People living with certain autoimmune diseases face a meaningfully higher risk of developing uveitis. These conditions include ankylosing spondylitis (an inflammatory disease of the spine), inflammatory bowel disease, rheumatoid arthritis, lupus, sarcoidosis, and Behcet disease. A genetic marker called HLA-B27 is strongly associated with acute anterior uveitis and is found in a significant number of patients who develop this form of the condition.
Several infections can trigger uveitis as part of the body's immune response. These include herpes simplex virus, herpes zoster (the virus that causes shingles), syphilis, toxoplasmosis (a parasitic infection), tuberculosis, and Lyme disease. When an infection is identified as the cause, treating the underlying infection is an essential part of resolving the eye inflammation safely.
Certain medications can trigger uveitis, including bisphosphonates (used to treat osteoporosis), checkpoint inhibitors (used in some cancer treatments), and some live vaccines. Smoking is a known risk factor as well. The composition of gut bacteria, hormonal differences, and broader environmental factors may also play a role in who develops the condition.
Signs and Symptoms of Uveitis
The symptoms of uveitis vary depending on which part of the eye is affected. Some people notice changes that develop rapidly over hours or days, while others with intermediate or posterior uveitis may experience subtle symptoms that gradually worsen without obvious pain.
Most people with uveitis notice one or more of the following warning signs. Prompt evaluation is important because even mild symptoms can indicate significant inflammation inside the eye.
- Eye pain or a deep aching sensation
- Redness in the white of the eye
- Sensitivity to light, a symptom called photophobia
- Blurred or decreased vision
- Floaters, which are dark spots, threads, or shapes that drift across your field of vision
Some symptoms are warning signs of serious and potentially permanent damage inside the eye. If you experience sudden eye pain with redness, a rapid increase in floaters, flashes of light, a shadow or curtain spreading across your vision, or sudden vision loss, seek immediate care from a retina specialist or go to the emergency room. Delaying treatment in these situations can lead to irreversible vision loss.
Anterior uveitis typically produces the most noticeable pain and redness because the front of the eye is involved. Intermediate and posterior uveitis may cause fewer outward signs, but significant floaters and blurring can still indicate serious inflammation. Panuveitis may involve the full range of symptoms at once. Posterior uveitis is particularly concerning because it directly involves the retina, the light-sensitive tissue responsible for central vision.
Diagnosis and Testing
Accurately diagnosing uveitis requires a thorough evaluation that goes beyond a routine eye exam. Our retina specialists use a combination of clinical examination, advanced imaging, and laboratory testing to identify the type of uveitis and its underlying cause.
The evaluation begins with a detailed eye examination using a slit lamp, a specialized microscope that provides a magnified view of both the front and back of the eye. Your specialist will look for inflammatory cells floating in the fluid inside the eye, protein deposits on the back of the cornea, and swelling in the retina. This exam provides essential information about the severity and location of the inflammation.
Several imaging tests help evaluate the extent of uveitis and detect complications that may not yet be causing noticeable symptoms.
- Optical coherence tomography (OCT) creates detailed cross-sectional images of the retina and can detect macular edema, which is swelling in the central part of the retina that affects sharp, central vision.
- Fluorescein angiography involves injecting a safe dye into a vein and photographing the blood vessels in the retina to check for leakage or damage caused by inflammation.
- Ultrasound imaging may be used when inflammation makes it difficult to clearly view the back of the eye through standard examination.
Because uveitis is often linked to systemic conditions or infections, your specialist may order blood tests and other laboratory work. Testing may check for HLA-B27, markers of sarcoidosis, syphilis, tuberculosis, and other relevant conditions. Identifying an underlying cause helps guide the safest and most effective treatment plan. When no specific cause can be found, the condition is called idiopathic uveitis, and treatment focuses on controlling the inflammation itself.
A system developed by the Standardization of Uveitis Nomenclature (SUN) Working Group provides classification criteria for 25 specific types of uveitis, helping specialists diagnose the condition more precisely and consistently. Machine learning tools are increasingly being applied to these criteria to support diagnostic accuracy and advance research into new treatments.
Treatment Options for Uveitis
Treatment for uveitis depends on the type, severity, and underlying cause. Our retina specialists develop individualized treatment plans designed to control inflammation, protect vision, and minimize risks from long-term medication use.
Corticosteroids are the most commonly used first treatment for uveitis because they reduce inflammation quickly. The form of delivery depends on the type and severity of the condition.
- Topical eye drops are used for anterior uveitis and are typically applied frequently at first, then tapered as inflammation improves.
- Periocular injections, which are given around the eye, address intermediate or posterior inflammation.
- Intravitreal injections are delivered directly into the eye for more severe or persistent cases. Clinical evidence has shown that intravitreal steroid delivery is more effective than periocular delivery for uveitic macular edema.
- Oral corticosteroids may be used for widespread or bilateral (both eyes) inflammation.
For intermediate, posterior, or panuveitis, a retina specialist may recommend placing a steroid implant inside the eye. The Ozurdex implant is a biodegradable device that releases dexamethasone over several months. The Retisert implant is a longer-lasting surgical device that can deliver fluocinolone acetonide for up to three years. Both options provide sustained, targeted treatment directly at the site of inflammation, reducing the need for frequent injections or systemic medication.
When uveitis is chronic or when prolonged steroid use poses risks such as cataract formation or elevated eye pressure, your specialist may introduce steroid-sparing medications. Methotrexate is the most commonly used option and clinical evidence has shown it to be as effective as, or more effective than, mycophenolate mofetil, particularly for posterior uveitis and panuveitis. Mycophenolate mofetil remains an alternative for patients who cannot tolerate methotrexate. Patients on these medications typically need regular blood tests to monitor for side effects.
For severe or treatment-resistant uveitis, biologic medications that target specific parts of the immune response may be used. Adalimumab is the only FDA-approved systemic biologic for adult noninfectious intermediate, posterior, and panuveitis. Multiple biosimilar versions of this medication have become available in recent years, improving access for patients who need it. Research into other biologic approaches, including therapies targeting IL-6 and IL-35 pathways, continues to advance with promising early results.
When uveitis is caused by an infection, treating that infection is a critical part of care. Antiviral, antibiotic, antifungal, or antiparasitic medications may be prescribed depending on the specific organism involved. In infection-related cases, using immunosuppressive drugs without first addressing the infection could make the condition significantly worse, so careful evaluation of the cause is essential before starting treatment.
Living With Uveitis
Managing uveitis is not just about the treatments you receive in the clinic. Long-term outcomes depend on consistent follow-up, attention to overall health, and recognizing complications early so they can be addressed before they affect vision permanently.
When inflammation is not fully controlled, uveitis can lead to several secondary conditions that require their own treatment.
- Cystoid macular edema, or swelling in the center of the retina, which can reduce central vision and affect reading and detail recognition
- Cataracts, a clouding of the natural lens inside the eye that causes gradual vision blur
- Glaucoma, a rise in eye pressure that can damage the optic nerve over time
- Retinal detachment, where the retina separates from the back of the eye, a condition that requires urgent treatment
- Permanent vision loss in severe or inadequately treated cases
Many people with acute anterior uveitis respond well to treatment and maintain good visual function. Chronic and posterior forms of uveitis tend to require longer, more complex treatment plans. With consistent monitoring and appropriate therapy, many patients are able to protect useful vision over the long term. Early treatment is the single most important factor in preventing lasting damage.
Even when your eyes feel comfortable and your vision seems stable, uveitis can return without obvious warning. Regular follow-up appointments allow your specialist to detect early signs of a flare through imaging and examination before symptoms become noticeable. Keeping all scheduled visits is one of the most effective ways to protect your vision over time.
Because uveitis is often connected to autoimmune or systemic inflammatory conditions, working with your primary care physician, rheumatologist, or other specialists to manage those conditions is an important part of your overall plan. Keeping underlying diseases well controlled can reduce the frequency and severity of uveitis flares. If you smoke, quitting is strongly recommended, as smoking is a known risk factor that can worsen uveitis outcomes.
Frequently Asked Questions
These questions address common concerns about uveitis that go beyond the general information covered above, including practical guidance on when to act and what to expect over time.
Yes, uveitis can cause permanent vision loss, particularly when it is severe, involves the retina, or goes untreated for too long. However, the risk is meaningfully lower when the condition is diagnosed early and managed consistently. The most important step you can take is seeking care promptly when symptoms first appear and following the treatment plan your specialist recommends. Even patients with chronic forms of uveitis can maintain useful vision for many years with proper management.
Uveitis itself is not contagious and cannot be passed from one person to another. In cases where an infection triggers the inflammation, such as herpes or toxoplasmosis, the underlying infection may have its own transmission concerns. However, the eye inflammation that develops is an immune response within your own body and does not transfer through contact with others.
Duration varies considerably depending on the type and your individual response to treatment. Acute anterior uveitis often resolves within a few weeks when treated promptly. Posterior uveitis and panuveitis are more likely to last for months and may require ongoing medication even after symptoms improve. Your specialist will monitor your response closely and adjust your treatment timeline accordingly rather than applying a fixed schedule.
Not everyone with uveitis requires lifelong treatment. Some patients experience a single episode that resolves fully with a short course of therapy and never returns. Others with recurrent or chronic uveitis need long-term immunosuppressive medication to prevent future flares and preserve their vision. Your specialist will aim to find the lowest effective level of treatment and will reassess your regimen regularly based on how your eyes are responding over time.
Yes, regular screening is important for children who have juvenile idiopathic arthritis or other autoimmune conditions. Uveitis in children often develops silently, without the pain or redness that typically prompts adults to seek care, which means it can progress and cause damage before it is noticed. Routine eye examinations by a specialist who is familiar with pediatric uveitis allow early detection and treatment before vision is affected.
Any sudden change in vision, a rapid increase in floaters, new flashes of light, or a shadow or curtain appearing in your vision should prompt you to seek same-day evaluation rather than waiting for a scheduled visit. These symptoms can indicate that uveitis or a related complication is causing active damage inside the eye. When in doubt, it is always safer to be evaluated promptly. Early intervention consistently leads to better outcomes than delayed care.
Expert Uveitis Care at Rhode Island Eye Institute
At Rhode Island Eye Institute, our fellowship-trained retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, provide experienced, personalized care for every form of uveitis, from a single acute episode to complex chronic disease requiring long-term management. We are proud to serve patients throughout Rhode Island and southeastern Massachusetts with the advanced diagnostic tools and treatment options needed to protect your vision. If you are experiencing symptoms or have been referred for evaluation, we welcome you to our practice and are here to help you through every step of your care.